Always Remember - Buy The Dip

Sentiment Analysis For TSRO

The news is currently generally neutral for TSRO.

Based on TextBlob analysis of Yahoo! Finance news summaries for TSRO on 2015-03-03.

Yahoo! Finance News for TSRO

TESARO (TSRO) is in Overbought Territory: What's Next? - Tale of the Tape
TESARO Inc ( TSRO ) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because TSRO is now in overbought territory with an RSI value of 76.02.What is

Earnings Reported After The Bell Feb. 19
Earnings Reported After The Bell Feb. 19

Insiders Were Right: TSRO Makes New 52-Week High
In trading on Thursday, shares of Tesaro Inc (Symbol TSRO) touched a new 52 week high of $41.56 share. That's a 87.63% rise, or $19.41 per share from the 52 week low of $22.15 set back on 05 09

Interesting TSRO Put And Call Options For February 20th
Investors in Tesaro Inc (Symbol TSRO) saw new options begin trading this week, for the February 20th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the TSRO options chain for the new February

Myriad Genetics, Tesaro Tie Up for myChoice Cancer Test - Analyst Blog
California based molecular diagnostic provider Myriad Genetics, Inc. ( MYGN ) recently formed a companion diagnostic alliance with with Massachusetts based Tesaro, Inc. ( TSRO ) an oncology focused biopharmaceutical company. Per the definitive agreement, Tesaro will use Myriad's

Weakness Seen in Tesaro, Inc. (TSRO): Stock Tumbles 9.0% - Tale of the Tape
Tesaro, Inc. ( TSRO ) saw a big move last session, as the company's shares fell by over 9% on the day. The move came on pretty good volume too with far more shares changing hands than in a

TESARO Seeks FDA Approval for NK-1 Receptor Rolapitant - Analyst Blog
TESARO, Inc. ( TSRO ) submitted a new drug application (NDA) for its pipeline candidate, oral rolapitant, to the FDA. TESARO shares gained 1.6% on the news. Rolapitant, which is a potent and selective neurokinin 1 (NK 1) receptor

Sector Update: Health Care
Healthcare stocks were narrowly mixed at the close with the NYSE Healthcare Sector Index declining about 0.2% and shares of healthcare companies in the S&P 500 adding about 0.1% as a group. In company news, Opko Health (OPKO) was

Sector Update: Health Care Stocks End Mixed; Opko Health, Tesaro Climb After Submitting New Drug Application for Anti-Nausea Medication
Top Healthcare Stocks JNJ 0.35% PFE 0.84% ABT 0.33% MRK 0.21% AMGN +1.01% Healthcare stocks were narrowly mixed at the close with the NYSE Healthcare Sector Index declining about 0.2% and shares of healthcare companies in the S&P 500

TESARO (TSRO) Slips on Wider-than-Expected Q2 Loss - Analyst Blog
TESARO, Inc. 's ( TSRO ) shares continued to decline after the company reported a wider than expected loss for the second quarter of 2014. Shares, which declined 5.2% immediately after the release of second quarter results, slipped a

Myriad Genetics Poised on Strong Fundamentals - Analyst Blog
On July 9, we issued an updated research report on leading molecular diagnostic company Myriad Genetics Inc. ( MYGN ). While we are impressed with the company's strong fundamentals, as once again reflected in the last reported quarter's financial

Commit To Purchase Tesaro At $25, Earn 14.2% Annualized Using Options
Investors eyeing a purchase of Tesaro Inc (Symbol TSRO) stock, but tentative about paying the going market price of $33.13 share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in

Tesaro (TSRO) in Focus: Stock Moves 8.9% Higher - Tale of the Tape
Tesaro, Inc. ( TSRO ) was a big mover last session with shares rising nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues

TSRO Makes Bullish Cross Above Critical Moving Average
In trading on Tuesday, shares of Tesaro Inc (Symbol TSRO) crossed above their 200 day moving average of $32.35, changing hands as high as $34.30 per share. Tesaro Inc shares are currently trading up about 9.9% on the day.

OPKO CEO Is Building A Pharma Powerhouse And Continuously Buying Shares
OPKO Health ( OPK ) has come to my attention because I noticed that the chairman and CEO, Dr. Phillip Frost , has been consistently showing up on the list of CEO buys at GuruFocus. As I look back

Tesaro, Inc. (TSRO) Looks Strong as Stock Rallies 21% - Tale of the Tape
Tesaro, Inc. ( TSRO ) was a big mover last session, as its shares surge 21% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This broke